Skip to main content
. 2010 Nov;105(11):2002–2013. doi: 10.1111/j.1360-0443.2010.03058.x

Figure 2.

Figure 2

Cumulative contributions of immediate quitters (IQs) and delayed quitters (DQs) to continuous abstinence rates, week X to week 12. Varenicline versus bupropion SR IQs (24.0%, 18.0%; P= 0.007); DQs (20.0%, 11.6%; P< 0.001). Varenicline versus placebo IQs (24.0%, 10.2%; P< 0.001); DQs (20.0%, 7.5%; P < 0.001). Bupropion SR versus placebo IQs (18.0%, 10.2%; P< 0.001) and DQs (11.6%, 7.5%; P= 0.009)